» Articles » PMID: 34982558

Deep Time Course Proteomics of SARS-CoV- and SARS-CoV-2-Infected Human Lung Epithelial Cells (Calu-3) Reveals Strong Induction of Interferon-Stimulated Gene Expression by SARS-CoV-2 in Contrast to SARS-CoV

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2022 Jan 4
PMID 34982558
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute respiratory syndrome (SARS)-CoV and SARS-CoV-2 infections are characterized by remarkable differences, including infectivity and case fatality rate. The underlying mechanisms are not well understood, illustrating major knowledge gaps of coronavirus biology. In this study, protein expression of the SARS-CoV- and SARS-CoV-2-infected human lung epithelial cell line Calu-3 was analyzed using data-independent acquisition-mass spectrometry. This resulted in a comprehensive map of infection-related proteome-wide expression changes in human cells covering the quantification of 7478 proteins across four time points. Most notably, the activation of interferon type-I response was observed, which is surprisingly absent in several proteome studies. The data reveal that SARS-CoV-2 triggers interferon-stimulated gene expression much stronger than SARS-CoV, which reflects the already described differences in interferon sensitivity. Potentially, this may be caused by the enhanced abundance of the viral M protein of SARS-CoV in comparison to SARS-CoV-2, which is a known inhibitor of type I interferon expression. This study expands the knowledge on the host response to SARS-CoV-2 infections on a global scale using an infection model, which seems to be well suited to analyze the innate immunity.

Citing Articles

The Nucleocapsid (N) Proteins of Different Human Coronaviruses Demonstrate a Variable Capacity to Induce the Formation of Cytoplasmic Condensates.

Tikhomirova M, Kuzmenko O, Arifulin E, Shirokova O, Musinova Y, Sheval E Int J Mol Sci. 2024; 25(23).

PMID: 39684875 PMC: 11642284. DOI: 10.3390/ijms252313162.


Dynamic Cellular Proteome Remodeling during SARS-CoV-2 Infection. Identification of Plasma Protein Readouts.

Dos Santos F, Vindel-Alfageme J, Ciordia S, Castro V, Orera I, Garaigorta U J Proteome Res. 2024; 24(1):171-188.

PMID: 39593238 PMC: 11705369. DOI: 10.1021/acs.jproteome.4c00566.


OmicScope unravels systems-level insights from quantitative proteomics data.

Reis-de-Oliveira G, Carregari V, Sousa G, Martins-de-Souza D Nat Commun. 2024; 15(1):6510.

PMID: 39095347 PMC: 11297029. DOI: 10.1038/s41467-024-50875-z.


Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.

Yang Z, Johnson B, Meliopoulos V, Ju X, Zhang P, Hughes M Cell Rep. 2024; 43(3):113965.

PMID: 38492217 PMC: 11044841. DOI: 10.1016/j.celrep.2024.113965.


Proteomic profiling identifies biomarkers of COVID-19 severity.

Harriott N, Ryan A Heliyon. 2024; 10(1):e23320.

PMID: 38163173 PMC: 10755324. DOI: 10.1016/j.heliyon.2023.e23320.